Efficacy, Durability and Safety of Faricimab in Neovascular Age-Related Macular Degeneration and Diabetic Macular Oedema: Lessons Learned from Registration Trials

被引：0
|
作者：
Helene O. Larsen
Jakob Grauslund
Anna S. Vergmann
机构：
[1] Odense University Hospital,Research Unit of Ophthalmology, Department of Ophthalmology
[2] University of Southern Denmark,Department of Clinical Research
[3] Odense University Hospital,Steno Diabetes Center Odense
[4] Vestfold Hospital Trust,Department of Ophthalmology
来源：
Ophthalmology and Therapy | 2023年 / 12卷
关键词：
Faricimab; Neovascular age-related macular degeneration; Diabetic macular oedema;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2253 / 2264
页数：11
相关论文
共 50 条
  • [41] DUAL PATHWAY INHIBITION WITH FARICIMAB FOR PREVIOUSLY TREATED NEOVASCULAR AGE RELATED MACULAR DEGENERATION AND DIABETIC MACULAR OEDEMA: GUIDANCE FROM A UK PANEL OF RETINA SPECIALISTS
    Downey, Louise
    Sivaprasad, Sobha
    Chhabra, Romi R.
    Bailey, Clare
    Chakrabarti, Soma
    Lotery, Andrew
    Patel, Jignesh
    Silvestri, Julie
    Watson, Sarah-Lucie
    Williams, Gwyn
    Elsherbiny, Samer
    Khokhar, Saima
    Parker, Antony
    EYE, 2024, 38 : 160 - 161
  • [42] Faricimab in neovascular age-related macular degeneration: Week 48 results from the phase 3 TENAYA and LUCERNE trials
    Guymer, Robyn H.
    Holz, Frank G.
    Lin, Hugh
    Basu, Karen
    Ruiz, Carlos Quezada
    Wong, Tien Y.
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 49 (08): : 835 - 835
  • [43] The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study – 6 month results
    Arshad M. Khanani
    Aamir A. Aziz
    Hannah Khan
    Ashwin Gupta
    Ohidul Mojumder
    Aigerim Saulebayeva
    Ashkan M. Abbey
    David R. P. Almeida
    Robert L. Avery
    Himanshu K. Banda
    Mark R. Barakat
    Ramanath Bhandari
    Emmanuel Y. Chang
    Sara J. Haug
    Nikolas J. S. London
    Luke Mein
    Veeral S. Sheth
    Jeremy D. Wolfe
    Michael A. Singer
    Carl J. Danzig
    Eye, 2023, 37 : 3574 - 3581
  • [44] AGE-RELATED MACULAR DEGENERATION - FROM NEOVASCULAR TO ATROPHIC
    ROY, M
    KUEHL, E
    ANNALS OF OPHTHALMOLOGY, 1989, 21 (11): : 429 - 431
  • [45] THE BURDEN OF DISEASE OF DIABETIC MACULAR EDEMA AND NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN PANAMA
    Hidalgo, J.
    Ordoñez, J.
    Avlia, P.
    Munoz, J. M.
    VALUE IN HEALTH, 2023, 26 (06) : S73 - S73
  • [46] Exploring Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema and Advances in Treatment
    Kim, Judy E.
    AMERICAN JOURNAL OF MANAGED CARE, 2022, 28 (03): : S35 - S43
  • [47] ECONOMIC BURDEN OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AND DIABETIC MACULAR EDEMA IN COLOMBIA
    Robles, A.
    Gil Rojas, Y.
    Amaya, D.
    Sardi Correa, C.
    Hernandez, F.
    VALUE IN HEALTH, 2022, 25 (12) : S71 - S72
  • [48] Emerging therapies for the treatment of neovascular age-related macular degeneration and diabetic macular edema
    Emerson, M. Vaughn
    Lauer, Andreas K.
    BIODRUGS, 2007, 21 (04) : 245 - 257
  • [49] THE BURDEN OF DISEASE OF DIABETIC MACULAR EDEMA AND NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN GUATEMALA
    Hidalgo, J.
    Ordonez, J.
    Deutschmann, B.
    Munoz, E.
    Arriola, A.
    Del Cid, J. M.
    Bustamante, W. Makepeace
    VALUE IN HEALTH, 2023, 26 (06) : S158 - S158
  • [50] Emerging Therapies for the Treatment of Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
    M. Vaughn Emerson
    Andreas K. Lauer
    BioDrugs, 2007, 21 : 245 - 257
12345